Top 5 Cannabis Angel Investors in United Kingdom

Last updated: Apr 2024 A list of 5 angel investors that invest in Cannabis startups based in United kingdom. We rank investors based on the number of investments they made in Cannabis companies from United kingdom. We update this investor list every month.

Top 5 Cannabis Angel Investors in United Kingdom

Investor	Cannabis United Kingdom investments
Christian Angermayer	3
Maria Raga	3
Julien Codorniou	1
Sophia Bendz	1
Irina Elena Haivas	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Christian Angermayer - Founder & CEO @ Apeiron Investment Group

Investment focus

Financial Services, FinTech, Blockchain
Seed, Series A, Series B
Germany, United States, United Kingdom

Portfolio highlights

TRIP — TRIP is the UK's most trusted CBD Oils and CBD Drinks Supplier. Shop the UK's best CBD oils available online with FREE UK Shipping.
Enhanced Games — Enhanced Games Home
Finclusion Group — Enhancing financial inclusion in Sub-Saharan Africa through data driven lending.

Maria Raga is the CEO of Depop. Since being promoted to the position in 2016 from VP of Operations, she has presided over every element of the business from finance and engineering to marketing and product. An open and collaborative CEO, Maria is dedicated to her team, which has grown to 150+ employees in 5 offices worldwide in the last threeyears alone. Perhaps most importantly, since she took over as CEO, she has raised close to $100M in funding, which has helped to grow and nurture the community on Depop - now 13 million users. Prior to Depop, Maria held successively roles at Groupon and Privalia. Having graduated from Insead MBA, Maria joined Bain & Company as a consultant. Born in Valencia, Spain, Maria now resides in London with her husband and 2 children. In her spare time, Maria enjoys connecting with Depop’s entrepreneurial Gen-Z constituency and promoting women in the workplace

Investment focus

Video, Mobile Apps, Transaction Processing
Seed, Series A, Angel
United Kingdom, France, Sweden

Portfolio highlights

Patient 21 — Patient21 believes that the doctor-patient connection is the cornerstone to good healthcare and that it is their responsibility to remove any impediments to it. They think that the greatest healthcare necessitates cross-specialty collaboration and universal data access. Always with one purpose in mind: to help patients and physicians make betterdecisions.In comparison to today's linked world, healthcare appears to be trapped in the past. It continues to use the same analogue and isolated processes. Patient21 is on a quest to usher healthcare into the twenty-first century. They use data to help doctors give the most personalized treatments possible. And, with the help of their professional network, they are attempting to give a comprehensive perspective of their client's health.
TRIP — TRIP is the UK's most trusted CBD Oils and CBD Drinks Supplier. Shop the UK's best CBD oils available online with FREE UK Shipping.
Omada — Get in on the action with Omada, the ultimate and insanely fun Sports Prediction Community.

Julien is an investor at Felix Capital where he focuses on SaaS (Worktech in particular) and gaming investments.Before joining Felix, Julien Codorniou spent 11 years at Facebook where he led the global platform partnerships team, helping Facebook partners to build, grow and monetize their mobile apps and games. From 2016 to 2021, he has beenserving as Vice President of Workplace. Under his leadership, Workplace went from 0 to 9 million paid subscribers at companies like Walmart, Grab, GSK, Nestlé, Chevron, MercadoLibre, ServiceNow, Astrazeneca, Lixil, Spotify, Save the Children and many more globally. Julien started his career in finance and before Facebook he was Director of Business Development at Microsoft Corp.Since 2012, Julien has served on the board of the French media group Le Monde. He is the co-author of the book: "The Kelkoo.com success story"published by Pearson in 2005.His former investments, as business angel include companies like TripleDot Studios, Bloom & Wild, Pigment, Xentral, Homesome, Olio, Peanut, Nabla, Curio, Linktree, Airlift Technologies and Sunday.He grew up in France and now lives in London with his wife and their two boys.

Investment focus

Software, E-Commerce, Apps
Seed, Series A, Pre-Seed
France, United Kingdom, United States

Portfolio highlights

5Mins — 5Mins is the new microlearning platform that helps your employees build in-demand skills fast with AI-powered personalisation and advanced gamification.
Sharpist — We offer personalized learning that will help people-centric organizations and teams grow throughout the challenges of today and tomorrow. Learn more!
Dust — Dust is a platform for creating sophisticated processes based on large language models and semantic search.

Sophia Bendz - Partner @ Cherry Ventures

Investment focus

Health Care, Software, Apps
Seed, Pre-Seed, Funding Round
Sweden, United Kingdom, United States

Portfolio highlights

mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.

Irina Haivas is a Principal. Based in London, she works on sourcing and due diligence of global investment opportunities.Irina focuses on businesses that use advanced technologies such as machine intelligence or robotics and automation, to transform large industries. She also focuses on the intersection of science and technology, including nextgeneration biology, as well as on companies in healthcare.Before joining Atomico, Irina was a growth and PE investor at GHO Capital Partners, where she invested, among others, in enterprise software and AI/ML businesses and focused on the intersection of science, healthcare and technology. Before that, Irina was part of the leadership team of Bain & Co. in Europe and the U.S., where she worked directly both with private equity firms on investment diligence, as well as with corporates on Innovation and Product, Go-to-Market, BD and acquisitions, and organisation scale-up. While at Bain she seconded in an operational role at Medtronic, one of the world’s largest medical engineering companies.Irina is a former surgeon, having studied medicine at Freiburg University in Germany and Iasi Medical University in Romania. She was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics.Irina speaks Romanian, English, advanced German, and conversational French.